Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
fda
15 min read • June 29, 2018
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
3 min read • June 26, 2018
420 Investor: Cannabis Drug Approval Creates ‘Logic Issue’ For The US Government
2 min read • June 25, 2018
GW Pharma’s Epidiolex Becomes First Cannabis-Based FDA-Approved Drug
1 min read • June 25, 2018
‘FDA sends pre-emptive warning to anyone trying to peddle unapproved uses of medical marijuana or cannabidiol, now that $GWPH approved @SGottliebFDA statement’-STAT’s Adam Feuerstein Tweets
1 min read • April 19, 2018
FDA Panel Unanimously Votes To Say Benefits Of Co.’s Cannabis-Derived Treatment For Severe Childhood Epilepsy Outweigh Its Risks
5 min read • January 25, 2018
Why GW Pharma’s Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics
4 min read • March 14, 2017
Trump, Sessions, Spicer And Medical Marijuana: Industry Insiders Discuss The Future Of Cannabis
3 min read • March 3, 2017
What A Federal Crackdown Could Mean For The First Public Marijuana REIT
6 min read • January 10, 2017
Top Cannabis Industry Experts Share 17 Predictions For Marijuana Markets In 2017 – Part 1
2 min read • January 6, 2016
Zynerba Pharmaceuticals Reports Positive Initial Results From ZYN002 CBD Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1 Multiple Rising Dose Trial
3 min read • October 27, 2015
GW Pharmaceuticals and the Government of New South Wales Report a Strategic Agreement to Study Epidiolex and CBDV in a Clinical Trial and Research Program for Children With Epilepsy
1 min read • March 31, 2011
Cannabis Science Ticks Higher On Cancer News Rumors (CBIS)
Latest Headlines
View All
8 min read • September 1, 2026
BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future
2 min read • September 1, 2026
House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown
3 min read • September 1, 2026
Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split
13 min read • September 1, 2026
Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal
6 min read • September 1, 2026
Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.
4 min read • August 31, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2
5 min read • August 31, 2026
Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell
6 min read • August 31, 2026
USCR Urges Congress to Keep the Hemp Loophole Closed
4 min read • August 28, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1
3 min read • August 28, 2026
$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says
2 min read • August 28, 2026
PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off
5 min read • August 27, 2026
Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.